Pharmacological Considerations during Percutaneous Treatment of Heart Failure
- Авторы: Sorolla-Romero J.1, Navarrete-Navarro J.1, Martinez-Sole J.1, Garcia H.2, Diez-Gil J.1, Martinez-Dolz L.1, Sanz-Sanchez J.1
-
Учреждения:
- Department of Cardiology, Hospital Universitari i Politècnic La Fe
- Department of Cardiology, MedStar Washington Hospital Cente
- Выпуск: Том 30, № 8 (2024)
- Страницы: 565-577
- Раздел: Immunology, Inflammation & Allergy
- URL: https://vestnikugrasu.org/1381-6128/article/view/646011
- DOI: https://doi.org/10.2174/0113816128284131240209113009
- ID: 646011
Цитировать
Полный текст
Аннотация
Heart Failure (HF) remains a global health challenge, marked by its widespread prevalence and substantial resource utilization. Although the prognosis has improved in recent decades due to the treatments implemented, it continues to generate high morbidity and mortality in the medium to long term. Interventional cardiology has emerged as a crucial player in HF management, offering a diverse array of percutaneous treatments for both acute and chronic HF. This article aimed to provide a comprehensive review of the role of percutaneous interventions in HF patients, with a primary focus on key features, clinical effectiveness, and safety outcomes. Despite the growing utilization of these interventions, there remain critical gaps in the existing body of evidence. Consequently, the need for high-quality randomized clinical trials and extensive international registries is emphasized to shed light on the specific patient populations and clinical scenarios that stand to benefit most from these innovative devices.
Ключевые слова
Об авторах
Jose Sorolla-Romero
Department of Cardiology, Hospital Universitari i Politècnic La Fe
Email: info@benthamscience.net
Javier Navarrete-Navarro
Department of Cardiology, Hospital Universitari i Politècnic La Fe
Email: info@benthamscience.net
Julia Martinez-Sole
Department of Cardiology, Hospital Universitari i Politècnic La Fe
Email: info@benthamscience.net
Hector Garcia
Department of Cardiology, MedStar Washington Hospital Cente
Email: info@benthamscience.net
Jose Diez-Gil
Department of Cardiology, Hospital Universitari i Politècnic La Fe
Email: info@benthamscience.net
Luis Martinez-Dolz
Department of Cardiology, Hospital Universitari i Politècnic La Fe
Email: info@benthamscience.net
Jorge Sanz-Sanchez
Department of Cardiology, Hospital Universitari i Politècnic La Fe
Автор, ответственный за переписку.
Email: info@benthamscience.net
Список литературы
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42(36): 3599-726. doi: 10.1093/eurheartj/ehab368 PMID: 34447992
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Am Coll Cardiol 2022; 79(17): e263-421. doi: 10.1016/j.jacc.2021.12.012 PMID: 35379503
- Eltayeb M, Squire I, Sze S. Biomarkers in heart failure: A focus on natriuretic peptides. Heart 2023. doi: 10.1136/heartjnl-2020-318553
- Lan T, Liao YH, Zhang J, et al. Mortality and readmission rates after heart failure: A systematic review and meta-analysis. Ther Clin Risk Manag 2021; 17: 1307-20. doi: 10.2147/TCRM.S340587 PMID: 34908840
- Taylor CJ, Ordóñez-Mena JM, Roalfe AK, et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: Population based cohort study. BMJ 2019; 364: l223. doi: 10.1136/bmj.l223 PMID: 30760447
- Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. J Am Heart Assoc 2019; 8(8): e011991. doi: 10.1161/JAHA.119.011991 PMID: 30947630
- Lee JM, Rhee TM, Hahn JY, et al. Multivessel percutaneous coronary intervention in patients with st-segment elevation myocardial infarction with cardiogenic shock. J Am Coll Cardiol 2018; 71(8): 844-56. doi: 10.1016/j.jacc.2017.12.028 PMID: 29471935
- Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant 2009; 28(8): 827-33. doi: 10.1016/j.healun.2009.04.033 PMID: 19632580
- Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization. J Am Coll Cardiol 2022; 79(2): e21-e129. doi: 10.1016/j.jacc.2021.09.006 PMID: 34895950
- Papaioannou TG, Stefanadis C. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance. ASAIO J 2005; 51(3): 296-300. doi: 10.1097/01.MAT.0000159381.97773.9B PMID: 15968962
- Thiele H, Zeymer U, Thelemann N, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction. Circulation 2019; 139(3): 395-403. doi: 10.1161/CIRCULATIONAHA.118.038201 PMID: 30586721
- Vargas KG, Jäger B, Kaufmann CC, et al. Impella in cardiogenic shock following acute myocardial infarction: A systematic review and meta-analysis. Wien Klin Wochenschr 2020; 132(23-24): 716-25. doi: 10.1007/s00508-020-01712-y PMID: 32691215
- Zein R, Patel C, Mercado-Alamo A, Schreiber T, Kaki A. A review of the Impella devices. Interv Cardiol 2022; 17: e05. doi: 10.15420/icr.2021.11 PMID: 35474971
- Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 2015; 34(12): 1549-60. doi: 10.1016/j.healun.2015.08.018 PMID: 26681124
- Zein R. A review of the Impella devices 2021. Available from: https://www.icrjournal.com/articles/review-impella-devices
- Impella ventricular support systems. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf14/p140003s018d.pdf
- Singh V, Yadav PK, Eng MH, et al. Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD Registry. Int J Cardiol 2017; 240: 120-5. doi: 10.1016/j.ijcard.2017.03.071 PMID: 28377189
- Impella ECP early feasibility study - Full text view. Available from: https://clinicaltrials.gov/ct2/show/NCT04477603
- Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52(19): 1584-8. doi: 10.1016/j.jacc.2008.05.065 PMID: 19007597
- Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017; 69(3): 278-87. doi: 10.1016/j.jacc.2016.10.022 PMID: 27810347
- Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation 2019; 139(10): 1249-58. doi: 10.1161/CIRCULATIONAHA.118.036614 PMID: 30586755
- ONeill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The PROTECT II study. Circulation 2012; 126(14): 1717-27. doi: 10.1161/CIRCULATIONAHA.112.098194 PMID: 22935569
- Kuchibhotla S, Esposito ML, Breton C, et al. Acute biventricular mechanical circulatory support for cardiogenic shock. J Am Heart Assoc 2017; 6(10): e006670. doi: 10.1161/JAHA.117.006670 PMID: 29054842
- Cheung AW, White CW, Davis MK, Freed DH. Short-term mechanical circulatory support for recovery from acute right ventricular failure: Clinical outcomes. J Heart Lung Transplant 2014; 33(8): 794-9. doi: 10.1016/j.healun.2014.02.028 PMID: 24726682
- Pivato CA, Ferrante G, Briani M, Sanz Sanchez J, Reimers B, Pagnotta P. Mitraclip treatment for severe mitral regurgitation due to chordae rupture following Impella CP support in a patient with severe aortic stenosis. Cardiovasc Revasc Med 2021; 28: 118-20. doi: 10.1016/j.carrev.2020.08.027 PMID: 32855084
- Aragon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv 2005; 65(3): 346-52. doi: 10.1002/ccd.20339 PMID: 15945107
- Burkhoff D, Cohen H, Brunckhorst C, ONeill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152(3): 469.e1-8. doi: 10.1016/j.ahj.2006.05.031 PMID: 16923414
- Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005; 26(13): 1276-83. doi: 10.1093/eurheartj/ehi161 PMID: 15734771
- Giesler GM, Gomez JS, Letsou G, Vooletich M, Smalling RW. Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction. Catheter Cardiovasc Interv 2006; 68(2): 263-6. doi: 10.1002/ccd.20846 PMID: 16819772
- Takagaki M, Wurzer C, Wade R, et al. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE. Ann Thorac Surg 2008; 86(5): 1677-9. doi: 10.1016/j.athoracsur.2008.04.101 PMID: 19049776
- Bajona P, Salizzoni S, Brann SH, et al. Prolonged use of right ventricular assist device for refractory graft failure following orthotopic heart transplantation. J Thorac Cardiovasc Surg 2010; 139(3): e53-4. doi: 10.1016/j.jtcvs.2008.10.042 PMID: 19660327
- Rajdev S, Benza R, Misra V. Use of tandem heart as a temporary hemodynamic support option for severe pulmonary artery hypertension complicated by cardiogenic shock. J Invasive Cardiol 2007; 19(8): E226-9. PMID: 17712211
- Kapur NK, Esposito ML, Bader Y, et al. Mechanical circulatory support devices for acute right ventricular failure. Circulation 2017; 136(3): 314-26. doi: 10.1161/CIRCULATIONAHA.116.025290 PMID: 28716832
- Ravichandran AK, Baran DA, Stelling K, Cowger JA, Salerno CT. Outcomes with the tandem protek duo dual-lumen percutaneous right ventricular assist device. ASAIO J Am Soc Artif Intern Organs 1992 1992; 64(4): 570-2.
- Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet 2020; 396(10245): 199-212. doi: 10.1016/S0140-6736(20)31047-3 PMID: 32682486
- Sheu JJ, Tsai TH, Lee FY, et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010; 38(9): 1810-7. doi: 10.1097/CCM.0b013e3181e8acf7 PMID: 20543669
- Ouweneel DM, Schotborgh JV, Limpens J, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: A systematic review and meta-analysis. Intensive Care Med 2016; 42(12): 1922-34. doi: 10.1007/s00134-016-4536-8 PMID: 27647331
- Rupprecht L, Lunz D, Philipp A, Lubnow M, Schmid C. Pitfalls in percutaneous ECMO cannulation. Heart Lung Vessel 2015; 7(4): 320-6. PMID: 26811838
- Conrad SA, Grier LR, Scott LK, Green R, Jordan M. Percutaneous cannulation for extracorporeal membrane oxygenation by intensivists: A retrospective single-institution case series. Crit Care Med 2015; 43(5): 1010-5. doi: 10.1097/CCM.0000000000000883 PMID: 25746749
- Makdisi G, Wang IW. Extra corporeal membrane oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 2015; 7(7): E166-76. PMID: 26380745
- Russo JJ, Aleksova N, Pitcher I, et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol 2019; 73(6): 654-62. doi: 10.1016/j.jacc.2018.10.085 PMID: 30765031
- Schrage B, Burkhoff D, Rübsamen N, et al. Unloading of the left ventricle during venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock. JACC Heart Fail 2018; 6(12): 1035-43. doi: 10.1016/j.jchf.2018.09.009 PMID: 30497643
- Cevasco M, Takayama H, Ando M, Garan AR, Naka Y, Takeda K. Left ventricular distension and venting strategies for patients on venoarterial extracorporeal membrane oxygenation. J Thorac Dis 2019; 11(4): 1676-83. doi: 10.21037/jtd.2019.03.29 PMID: 31179113
- Pasrija C, Bedeir K, Jeudy J, Kon ZN. Harlequin syndrome during venoarterial extracorporeal membrane oxygenation. Radiol Cardiothorac Imaging 2019; 1(2): e190031. doi: 10.1148/ryct.2019190031 PMID: 33778505
- Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020; 22(8): 1342-56. doi: 10.1002/ejhf.1858 PMID: 32483830
- van Riet EES, Hoes AW, Limburg A, Landman MAJ, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail 2014; 16(7): 772-7. doi: 10.1002/ejhf.110 PMID: 24863953
- van Riet EES, Hoes AW, Wagenaar KP, Limburg A, Landman MAJ, Rutten FH. Epidemiology of heart failure: The prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016; 18(3): 242-52. doi: 10.1002/ejhf.483 PMID: 26727047
- Stolfo D, Uijl A, Vedin O, et al. Sex-based differences in heart failure across the ejection fraction spectrum. JACC Heart Fail 2019; 7(6): 505-15. doi: 10.1016/j.jchf.2019.03.011 PMID: 31146874
- Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: A population-based study of 4 million individuals. Lancet 2018; 391(10120): 572-80. doi: 10.1016/S0140-6736(17)32520-5 PMID: 29174292
- McDonagh TA, Metra M, Adamo M, et al. 2023 focused update of the 2021 esc guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2023; 44(37): 3627-39. doi: 10.1093/eurheartj/ehad195 PMID: 37622666
- Martinez-Sole J, Sanchez-Martinez JC, Lopez-Vilella R, et al. Overview of the treatment of congestion in heart failure. Curr Pharm Des 2023; 29(20): 1592-601. doi: 10.2174/1381612829666230714153404 PMID: 37455461
- Goliasch G, Bartko PE, Pavo N, et al. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur Heart J 2018; 39(1): 39-46. doi: 10.1093/eurheartj/ehx402 PMID: 29020337
- Asmarats L, Taramasso M, Rodés-Cabau J. Tricuspid valve disease: Diagnosis, prognosis and management of a rapidly evolving field. Nat Rev Cardiol 2019; 16(9): 538-54. doi: 10.1038/s41569-019-0186-1 PMID: 30988448
- Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: Comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol 2014; 63(2): 185-6. doi: 10.1016/j.jacc.2013.08.723 PMID: 24036029
- Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 2011; 97(20): 1675-80. doi: 10.1136/hrt.2011.225789 PMID: 21807656
- Sannino A, Smith RL II, Schiattarella GG, Trimarco B, Esposito G, Grayburn PA. Survival and cardiovascular outcomes of patients with secondary mitral regurgitation. JAMA Cardiol 2017; 2(10): 1130-9. doi: 10.1001/jamacardio.2017.2976 PMID: 28877291
- Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: The emerging role of mitral regurgitation. Circulation 2005; 111(3): 295-301. doi: 10.1161/01.CIR.0000151097.30779.04 PMID: 15655133
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43(7): 561-632. doi: 10.1093/eurheartj/ehab395 PMID: 34453165
- Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: A simplified method to correct mitral insufficiency1. Eur J Cardiothorac Surg 1998; 13(3): 240-6. doi: 10.1016/S1010-7940(98)00014-1 PMID: 9628372
- Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011; 364(15): 1395-406. doi: 10.1056/NEJMoa1009355 PMID: 21463154
- Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018; 379(24): 2297-306. doi: 10.1056/NEJMoa1805374 PMID: 30145927
- Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018; 379(24): 2307-18. doi: 10.1056/NEJMoa1806640 PMID: 30280640
- Chehab O, Roberts-Thomson R, Ng Yin Ling C, et al. Secondary mitral regurgitation: Pathophysiology, proportionality and prognosis. Heart 2020; 106(10): 716-23. doi: 10.1136/heartjnl-2019-316238 PMID: 32054671
- Stone GW, Abraham WT, Lindenfeld J, et al. Five-year follow-up after transcatheter repair of secondary mitral regurgitation. N Engl J Med 2023; 388(22): 2037-48. doi: 10.1056/NEJMoa2300213 PMID: 36876756
- Lim DS, Kar S, Spargias K, et al. Transcatheter valve repair for patients with mitral regurgitation. JACC Cardiovasc Interv 2019; 12(14): 1369-78. doi: 10.1016/j.jcin.2019.04.034 PMID: 31255562
- Webb JG, Hensey M, Szerlip M, et al. 1-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study. JACC Cardiovasc Interv 2020; 13(20): 2344-57. doi: 10.1016/j.jcin.2020.06.019 PMID: 33092709
- De Backer O, Wong I, Taramasso M, Maisano F, Franzen O, Søndergaard L. Transcatheter mitral valve repair: An overview of current and future devices. Open Heart 2021; 8(1): e001564. doi: 10.1136/openhrt-2020-001564 PMID: 33911022
- McInerney A, Marroquin-Donday L, Tirado-Conte G, et al. Transcatheter treatment of mitral regurgitation. J Clin Med 2022; 11(10): 2921. doi: 10.3390/jcm11102921 PMID: 35629048
- Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 2019; 40(5): 441-51. doi: 10.1093/eurheartj/ehy590 PMID: 30357365
- Hensey M, Brown RA, Lal S, et al. Transcatheter mitral valve replacement. JACC Cardiovasc Interv 2021; 14(5): 489-500. doi: 10.1016/j.jcin.2020.12.038 PMID: 33663778
- Yoon SH, Bleiziffer S, Latib A, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv 2019; 12(2): 182-93. doi: 10.1016/j.jcin.2018.12.001 PMID: 30678797
- Webb J, Hensey M, Fam N, et al. Transcatheter mitral valve replacement with the transseptal EVOQUE system. JACC Cardiovasc Interv 2020; 13(20): 2418-26. doi: 10.1016/j.jcin.2020.06.040 PMID: 33092713
- Benfari G, Antoine C, Miller WL, et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation 2019; 140(3): 196-206. doi: 10.1161/CIRCULATIONAHA.118.038946 PMID: 31117814
- Kilic A, Saha-Chaudhuri P, Rankin JS, Conte JV. Trends and outcomes of tricuspid valve surgery in North America: An analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Ann Thorac Surg 2013; 96(5): 1546-52. doi: 10.1016/j.athoracsur.2013.06.031 PMID: 24070702
- Mesnier J, Alperi A, Panagides V, et al. Transcatheter tricuspid valve interventions: Current devices and associated evidence. Prog Cardiovasc Dis 2021; 69: 89-100. doi: 10.1016/j.pcad.2021.11.007 PMID: 34801577
- Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol 2019; 74(24): 2998-3008. doi: 10.1016/j.jacc.2019.09.028 PMID: 31568868
- Lurz P, Stephan von Bardeleben R, Weber M, et al. Transcatheter edge-to-edge repair for treatment of tricuspid regurgitation. J Am Coll Cardiol 2021; 77(3): 229-39. doi: 10.1016/j.jacc.2020.11.038 PMID: 33478646
- Lurz P, Besler C, Schmitz T, et al. Short-term outcomes of tricuspid edge-to-edge repair in clinical practice. J Am Coll Cardiol 2023; 82(4): 281-91. doi: 10.1016/j.jacc.2023.05.008 PMID: 37207923
- Kodali S, Hahn RT, Eleid MF, et al. Feasibility study of the transcatheter valve repair system for severe tricuspid regurgitation. J Am Coll Cardiol 2021; 77(4): 345-56. doi: 10.1016/j.jacc.2020.11.047 PMID: 33509390
- Alperi A, Almendárez M, Álvarez R, et al. Transcatheter tricuspid valve interventions: Current status and future perspectives. Front Cardiovasc Med 2022; 9: 994502. doi: 10.3389/fcvm.2022.994502 PMID: 36187002
- Abdul-Jawad Altisent O, Benetis R, Rumbinaite E, et al. Caval valve implantation (CAVI): An emerging therapy for treating severe tricuspid regurgitation. J Clin Med 2021; 10(19): 4601. doi: 10.3390/jcm10194601 PMID: 34640619
- Lauten A, Dreger H, Laule M, Stangl K, Figulla HR, Eng MH. Caval valve implantation. Interv Cardiol Clin 2022; 11(1): 95-102. PMID: 34838301
- Estévez-Loureiro R, Sánchez-Recalde A, Amat-Santos IJ, et al. 6- month outcomes of the tricvalve system in patients with tricuspid regurgitation. JACC Cardiovasc Interv 2022; 15(13): 1366-77. doi: 10.1016/j.jcin.2022.05.022 PMID: 35583363
- Dreger H, Mattig I, Hewing B, et al. Treatment of severe tricuspid regurgitation in patients with advanced heart failure with caval vein implantation of the edwards sapien xt valve (TRICAVAL): A randomised controlled trial. EuroIntervention 2020; 15(17): 1506-13. doi: 10.4244/EIJ-D-19-00901 PMID: 31929100
- Nickenig G, Friedrichs KP, Baldus S, et al. Thirty-day outcomes of the cardioband tricuspid system for patients with symptomatic functional tricuspid regurgitation: The TriBAND study. EuroIntervention 2021; 17(10): 809-17. doi: 10.4244/EIJ-D-21-00300 PMID: 34031021
- Radhoe SP, Veenis JF, Brugts JJ. Invasive devices and sensors for remote care of heart failure patients. Sensors 2021; 21(6): 2014. doi: 10.3390/s21062014 PMID: 33809205
- Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: The COMPASS-HF study. J Am Coll Cardiol 2008; 51(11): 1073-9. doi: 10.1016/j.jacc.2007.10.061 PMID: 18342224
- Adamson PB, Gold MR, Bennett T, et al. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: Results of the reducing decompensation events utilizing intracardiac pressures in patients with chronic heart failure (REDUCEhf) trial. Congest Heart Fail 2011; 17(5): 248-54. doi: 10.1111/j.1751-7133.2011.00247.x PMID: 21906250
- Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet 2011; 377(9766): 658-66. doi: 10.1016/S0140-6736(11)60101-3 PMID: 21315441
- Abraham WT, Adamson PB, Costanzo MR, et al. Hemodynamic monitoring in advanced heart failure: Results from the LAPTOP-HF trial. J Card Fail 2016; 22(11): 940. doi: 10.1016/j.cardfail.2016.09.012
- Udelson JE, Barker CM, Meduri C, et al. Six month results from first in human clinical experience of a no-implant interatrial shunt for heart failure with preserved ejection fraction. J Am Coll Cardiol 2022; 79(9) (Suppl.): 229-9. doi: 10.1016/S0735-1097(22)01220-7
- Rod és CJ, Bernier M, Amat -Santos Ignacio J, et al. Interatrial shunting for heart failure. JACC Cardiovasc Interv 2018; 11(2): 2300-10.
- Kaye DM, Nanayakkara S. Interatrial shunt device for heart failure with preserved ejection fraction. Front Cardiovasc Med 2019; 6: 143. doi: 10.3389/fcvm.2019.00143 PMID: 31620452
- Yi T, Li M, Fan F, et al. Haemodynamic changes of interatrial shunting devices for heart failure: A systematic review and meta-analysis. ESC Heart Fail 2022; 9(3): 1987-95. doi: 10.1002/ehf2.13911 PMID: 35322588
- Feldman T, Mauri L, Kahwash R, et al. Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I reduce elevated left atrial pressure in patients with heart failure). Circulation 2018; 137(4): 364-75. doi: 10.1161/CIRCULATIONAHA.117.032094 PMID: 29142012
- Shah SJ, Borlaug BA, Chung ES, et al. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): A randomised, multicentre, blinded, sham-controlled trial. Lancet 2022; 399(10330): 1130-40. doi: 10.1016/S0140-6736(22)00016-2 PMID: 35120593
- Adhyapak SM, Parachuri VR. Architecture of the left ventricle: Insights for optimal surgical ventricular restoration. Heart Fail Rev 2010; 15(1): 73-83. doi: 10.1007/s10741-009-9151-0 PMID: 19757029
- Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A scientific statement from the american heart association. Circulation 2019; 139(16): e840-78. doi: 10.1161/CIR.0000000000000664 PMID: 30852913
- Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53(7): 589-96. doi: 10.1016/j.jacc.2008.05.068 PMID: 19215833
- Nijst P, Martens P, Dupont M, Tang WHW, Mullens W. Intrarenal flow alterations during transition from euvolemia to intravascular volume expansion in heart failure patients. JACC Heart Fail 2017; 5(9): 672-81. doi: 10.1016/j.jchf.2017.05.006 PMID: 28711449
- Vora AN, Schuyler Jones W, DeVore AD, Ebner A, Clifton W, Patel MR. First-in-human experience with Aortix intraaortic pump. Catheter Cardiovasc Interv 2019; 93(3): 428-33. doi: 10.1002/ccd.27857 PMID: 30311400
- Zymliński R, Dierckx R, Biegus J, Vanderheyden M, Bartunek J, Ponikowski P. Novel IVC doraya catheter provides congestion relief in patients with acute heart failure. JACC Basic Transl Sci 2022; 7(3): 326-7. doi: 10.1016/j.jacbts.2022.02.013 PMID: 35411326
- Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003; 348(4): 295-303. doi: 10.1056/NEJMoa021332 PMID: 12540642
- Maron MS, Ommen SR. Exploring new and old therapies for obstructive hypertrophic cardiomyopathy. Circulation 2021; 143(12): 1181-3. doi: 10.1161/CIRCULATIONAHA.120.051330 PMID: 33750209
- Zhou M, Ta S, Hahn RT, et al. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy. JAMA Cardiol 2022; 7(5): 529-38. doi: 10.1001/jamacardio.2022.0259 PMID: 35353129
- Khan JM, Bruce CG, Greenbaum AB, et al. Transcatheter myotomy to relieve left ventricular outflow tract obstruction: The septal scoring along the midline endocardium procedure in animals. Circ Cardiovasc Interv 2022; 15(6): e011686. doi: 10.1161/CIRCINTERVENTIONS.121.011686 PMID: 35378990
Дополнительные файлы
